|
CHOLESTYRAMINE REDUCES ABSORPTION IF GIVEN WITHIN ONE HOUR OF EACH OTHER ORALLY, SO IT SHOULD BE GIVEN EITHER ATLEAST 1 HR BEFORE OR 4-6 HRS AFTER CHOLESTYRAMINE
|
CHOLESTYRAMINE REDUCES ABSORPTION IF GIVEN WITHIN ONE HOUR OF EACH OTHER ORALLY, SO IT SHOULD BE GIVEN EITHER ATLEAST 1 HR BEFORE OR 4-6 HRS AFTER CHOLESTYRAMINE
|
CHARCOAL, AN INTESTINAL ABSORBENT MAY REDUCE ITS ABSORPTION AND EFFECT
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|